Goldfarb Gross Seligman & Co.

Goldfarb Gross Seligman & Co. has broad exposure to the life sciences and healthcare industry, having maintained a key role in large M&A transactions, among them a $671m going private transaction for a major pharmaceutical company, as well as handling complex regulatory and licensing matters. Head of life sciences Hili Cohen is a key adviser to technology-based companies in the life sciences, medical devices, pharmaceuticals, digital health, telemedicine, diagnostics, and medical cannabis sectors. Corporate and commercial partner Danny Kleinhendler, emerging talent Shir Shalev, and Ofir Goldstein, who handles technology licensing agreements, investments, capital, and development agreements, are the standout practitioners in a diverse, multidisciplinary team.